Pharmaceutical industry
Hoton da AI ya samar
Grifols prepares stock listing for its US Biopharma business
An Ruwaito ta hanyar AI Hoton da AI ya samar
Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.